All posts by: Michael Zand

About Michael Zand

New type of stem cell produces two tissues for the price of one – New Atlas

Continue reading

2018-02-28 NEWS

New Atlas

New type of stem cell produces two tissues for the price of one
New Atlas
If you wind back the clock on the different cells in our bodies, they’d all start life as one of just a few types of stem cells. Now, researchers from the University of Queensland have wound back the clock even further, and discovered a new type of

Continue reading

2018-02-28 NEWS

CBS New York

Stem Cells Offer New Hope For Recovery From Rotator Cuff Surgery
CBS New York
NEW YORK (CBSNewYork) — Stem cells have shown promise for all sorts of medical issues for years. As CBS2’s Dr. Max Gomez reports, you can now add shoulder surgery to that list. It’s for the more than 3 million Americans who experience rotator cuff

and more »

Continue reading

2018-02-27 NEWS

Unique pancreatic stem cells have potential to regenerate beta cells, respond to glucose
Science Daily
“Our in-depth study of these pancreatic stem cells may help us tap into an endogenous cell supply ‘bank’ for beta cell regeneration purposes and, in the future, lead to therapeutic applications for people living with type 1 diabetes,” said Juan

and more »

Continue reading

2018-02-27 NEWS

OncLive

Bright Future for Gene Therapy in Hematologic Malignancies
OncLive
Chimeric antigen receptor (CAR) T-cell therapy has been named the Advance of the Year in the American Society of Clinical Oncology’s (ASCO’s) Clinical Cancer Advances 2018. 1 It’s not hard to understand why. CAR T-cell therapy is unique among

Continue reading

2018-02-27 NEWS

Florida Times-Union

Doctors are In: The age of gene therapy has arrived
Florida Times-Union
There are thousands of diseases that stem from an error in a single gene, including common diseases such as hemophilia and sickle cell disease. Thousands of other diseases, such as Alzheimer’s disease and heart disease, likely stem from abnormalities

Continue reading

2018-02-27 NEWS

Science Daily

Enabling technology for emerging gene therapies
Science Daily
That’s the Holy Grail of personalized medicine and emerging gene therapies.” Meacham’s work comes on the heels of an approval in August by the U.S. Food and Drug Administration of the first gene therapy using patient-derived immune cells in the U.S. A

and more »